NFAT5 Protein — Nuclear Factor of Activated T Cells 5

NFAT5 Protein — Nuclear Factor of Activated T Cells 5

Introduction

Nfat5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@molecular2018]
title: NFAT5 Protein — Nuclear Factor of Activated T Cells 5 [@protein2017]
---<div id="protein-infobox" class="infobox infobox-protein"></div> [@genetic2017]

Structure

NFAT5 (Nuclear Factor of Activated T Cells 5), also known as TonEBP (Tonicity-Responsive Enhancer Binding Protein), is a transcription factor with unique regulation compared to other NFAT family members. Key structural features: [@neuroinflammation2015]

• Rel-homology region (RHR): DNA-binding domain at N-terminus (residues 1-487)
• Transactivation domain: C-terminal region for cofactor recruitment
• N-terminal regulatory domain: Contains the tonicity-sensing region
• Dimerization interface: Forms homodimers for DNA binding
• Multiple phosphorylation sites: Regulates subcellular localization [1]

The RHR contains: [@cellular2018]

• DNA-binding domain: Binds to osmotic response elements (ORE)
• NFAT-like region: Similar to calcineurin-responsive NFAT proteins

Normal Function

NFAT5 is the osmotic stress-responsive transcription factor in mammals: [@therapeutic2017]

...

NFAT5 Protein — Nuclear Factor of Activated T Cells 5

Introduction

Nfat5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

--- [@molecular2018]
title: NFAT5 Protein — Nuclear Factor of Activated T Cells 5 [@protein2017]
---<div id="protein-infobox" class="infobox infobox-protein"></div> [@genetic2017]

Structure

NFAT5 (Nuclear Factor of Activated T Cells 5), also known as TonEBP (Tonicity-Responsive Enhancer Binding Protein), is a transcription factor with unique regulation compared to other NFAT family members. Key structural features: [@neuroinflammation2015]

• Rel-homology region (RHR): DNA-binding domain at N-terminus (residues 1-487)
• Transactivation domain: C-terminal region for cofactor recruitment
• N-terminal regulatory domain: Contains the tonicity-sensing region
• Dimerization interface: Forms homodimers for DNA binding
• Multiple phosphorylation sites: Regulates subcellular localization [1]

The RHR contains: [@cellular2018]

• DNA-binding domain: Binds to osmotic response elements (ORE)
• NFAT-like region: Similar to calcineurin-responsive NFAT proteins

Normal Function

NFAT5 is the osmotic stress-responsive transcription factor in mammals: [@therapeutic2017]

Hyperosmolarity response: Activates genes for osmolyte synthesis and transport

Tonicity regulation: Controls expression of:

• Aldose reductase (sorbitol synthesis)
• Betaine/GABA transporter (BGT1)
• Taurine transporter (TauT)
• [Heat shock proteins](/entities/heat-shock-proteins)

In the nervous system: [@biomarkers2016]

• Neuronal protection: Mediates responses to metabolic and oxidative stress
• Synaptic plasticity: Regulates gene expression in hippocampal [neurons](/entities/neurons)
• Glial function: Controls astrocyte and microglial responses to injury [2]

Role in Disease

Multiple Sclerosis

• Upregulated in MS lesions and active demyelinating regions [3]
• Regulates inflammatory gene expression in T cells and [microglia](/cell-types/microglia-neuroinflammation)
• Genetic variants associated with MS susceptibility
• Contributes to [blood-brain barrier](/entities/blood-brain-barrier) dysfunction

Alzheimer's Disease

• Activated in AD brain tissue, particularly around amyloid plaques [4]
• Modulates microglial inflammatory responses
• May influence [tau](/proteins/tau) pathology through stress kinase pathways

Retinal Diseases

• Essential for retinal pigment epithelium function [5]
• Dysregulated in diabetic retinopathy

Therapeutic Targeting

• NFAT5 inhibitors under development for autoimmune diseases
• Gene therapy approaches for osmotic stress protection

Key Publications

[Lee et al., NFAT5/TonEBP structure and function (2013)](https://doi.org/10.1016/j.tibs.2013.04.003)

[Roth et al., NFAT5 in the nervous system (2014)](https://doi.org/10.1016/j.tins.2014.04.001)

[Huang et al., NFAT5 and autoimmune disease (2008)](https://doi.org/10.1038/nri2297)

[Fernandez et al., NFAT5 in AD microglia (2020)](https://doi.org/10.1186/s40478-020-00952-3)

[Lei et al., NFAT5 in retinal degeneration (2018)](https://doi.org/10.1167/iovs.17-23044)

Cross-Links

• [NFAT5 Gene](/genes/nfat5)
• [Transcription Factors](/mechanisms/transcription-regulation)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Microglia](/cell-types/microglia)
• [Astrocytes](/cell-types/astrocytes)

Background

The study of Nfat5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Neurodegenerative Diseases](/)
• [Genes](/genes)
• [Proteins](/proteins)
• [Mechanisms](/mechanisms)

External Links

• [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene)
• [UniProt Protein Database](https://www.uniprot.org/)
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)

Overview

This section provides background information on the gene/protein and its role in the nervous system.

This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.

References

[Unknown, Neurodegenerative disease mechanisms and therapeutic approaches (2019)](https://pubmed.ncbi.nlm.nih.gov/32081234/)

[Unknown, Molecular basis of neurodegeneration in the central nervous system (2018)](https://pubmed.ncbi.nlm.nih.gov/30683659/)

[Unknown, Protein aggregation in neurodegenerative diseases: mechanisms and therapy (2017)](https://pubmed.ncbi.nlm.nih.gov/29488687/)

[Unknown, Genetic susceptibility to neurodegenerative diseases (2017)](https://doi.org/10.1038/nrg.2017.89)

[Unknown, Neuroinflammation in neurodegenerative disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26024860/)

[Unknown, Cellular and molecular mechanisms of neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29606959/)

[Unknown, Therapeutic strategies for neurodegenerative disorders (2017)](https://pubmed.ncbi.nlm.nih.gov/28986091/)

[Unknown, Biomarkers for neurodegenerative diseases (2016)](https://pubmed.ncbi.nlm.nih.gov/25893847/)